Optibumin – Lipid-Reduced Recombinant Human Albumin (rHSA)
Ideally suited for hydrophobic molecule solubilization, vaccine and cell therapy excipient, surgical sealant, select cell culture, and other clinical applications.
Bulk Pricing Available Upon Request >>
Ideally suited for hydrophobic molecule solubilization, vaccine and cell therapy excipient, surgical sealant, select cell culture, and other clinical applications.
Product Description
Optibumin is a lipid poor albumin that has been reduced to allow for maximal conjugation efficiency of different ligands for cell culture media optimization. Optibumin has exceptionally low endotoxin and high purity of mercaptoalbumin. Optibumin has been shown to be highly effective in certain cell culture applications such as human induced pluripotent stem cell expansion. This product is also suitable for use in formulation excipient and medical device applications.
Advantages
-
Manufactured in a tertiary level animal component-free facility in the United States
- Raw materials, manufacturing equipment, and packaging is certified animal-free
- Host manufacturing system is of non-animal and non-human source
- Complete supply and manufacturing chain is owned and operated by InVitria
- Supplied as a 20% liquid
- Certified ISO13485/ISO9001
- Optibumin is cGMP, injectable grade
